In patients with bladder cancer, the combined HER4/NRG4 signaling unit can be growth inhibitory, and the co-expression of HER4 together with NRG4 is highly correlated to better survival if the two proteins act together rather than individually [28]. The gene discussed is NRG4; the disease is urinary bladder carcinoma.